US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Kaleido Biosciences Inc (KLDO)
Kaleido Biosciences Inc (KLDO) ニュース

KLDO

Kaleido Biosciences (KLDO)

Kaleido Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:KLDO

1 2 3 4 5 6 7 8 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2022/05/06	21 : 16	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:KLDO	Kaleido Biosciences Inc
2022/05/02	19 : 20	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:KLDO	Kaleido Biosciences Inc
2022/04/27	18 : 03	TipRanks	Analysts Offer Insights on Healthcare Companies: and Kaleido Biosciences (KLDO)	NASDAQ:KLDO	Kaleido Biosciences Inc
2022/04/26	05 : 43	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:KLDO	Kaleido Biosciences Inc
2022/04/26	05 : 41	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:KLDO	Kaleido Biosciences Inc
2022/04/18	22 : 25	Edgar (US Regulatory)	Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)	NASDAQ:KLDO	Kaleido Biosciences Inc
2022/04/08	22 : 26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KLDO	Kaleido Biosciences Inc
2022/04/04	20 : 45	TipRanks	Kaleido Biosciences (KLDO) was Downgraded to a Hold Rating at Chardan Capital	NASDAQ:KLDO	Kaleido Biosciences Inc
2022/03/16	21 : 30	GlobeNewswire Inc.	Radius Health Announces Leadership Appointments	NASDAQ:KLDO	Kaleido Biosciences Inc
2022/03/10	06 : 26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KLDO	Kaleido Biosciences Inc
2022/03/03	06 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KLDO	Kaleido Biosciences Inc
2022/03/03	06 : 11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KLDO	Kaleido Biosciences Inc
2022/02/28	23 : 00	PR Newswire (US)	Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs	NASDAQ:KLDO	Kaleido Biosciences Inc
2022/02/16	00 : 05	PR Newswire (US)	INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT	NASDAQ:KLDO	Kaleido Biosciences Inc
2022/02/09	23 : 25	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:KLDO	Kaleido Biosciences Inc
2022/01/29	06 : 44	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KLDO	Kaleido Biosciences Inc
2022/01/22	01 : 04	GlobeNewswire Inc.	Kaleido Biosciences to Present Updated Data of KB295 In Ulcerative Colitis at the 2022 Crohn’s and Colitis Congress	NASDAQ:KLDO	Kaleido Biosciences Inc
2022/01/19	07 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KLDO	Kaleido Biosciences Inc
2022/01/19	07 : 13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KLDO	Kaleido Biosciences Inc
2022/01/19	07 : 12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KLDO	Kaleido Biosciences Inc
2022/01/19	07 : 10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KLDO	Kaleido Biosciences Inc
2021/12/17	07 : 19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KLDO	Kaleido Biosciences Inc
2021/12/17	07 : 17	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:KLDO	Kaleido Biosciences Inc
2021/12/06	21 : 30	GlobeNewswire Inc.	Kaleido Biosciences Announces Expansion of Collaboration with Janssen to Explore Potential of Microbiome Metabolic Therapies (MMT™) to Prevent Childhood-Onset of Atopic, Immune and Metabolic Conditions	NASDAQ:KLDO	Kaleido Biosciences Inc
2021/11/15	21 : 30	GlobeNewswire Inc.	Kaleido Biosciences to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference	NASDAQ:KLDO	Kaleido Biosciences Inc
2021/11/10	21 : 30	GlobeNewswire Inc.	Kaleido Biosciences to Appoint Dr. Alison Long as Chief Medical Officer	NASDAQ:KLDO	Kaleido Biosciences Inc
2021/11/01	20 : 30	GlobeNewswire Inc.	Kaleido Biosciences Reports Third Quarter 2021 Financial Results	NASDAQ:KLDO	Kaleido Biosciences Inc
2021/10/13	23 : 11	PR Newswire (US)	Invaio Sciences Secures $50 Million Debt Financing to Develop and Commercialize Agricultural Solutions to Address Climate Change	NASDAQ:KLDO	Kaleido Biosciences Inc
2021/10/12	20 : 30	GlobeNewswire Inc.	Kaleido Biosciences to Participate in the Jefferies Virtual Next Generation IBD Therapeutics Summit	NASDAQ:KLDO	Kaleido Biosciences Inc
2021/10/05	20 : 00	GlobeNewswire Inc.	Kaleido Biosciences Announces New Clinical and Preclinical Data Supporting Advancement of KB295 to a Phase 2 Clinical Study in Mild-to-Moderate Ulcerative Colitis	NASDAQ:KLDO	Kaleido Biosciences Inc

Showing the most relevant articles for your search:NASDAQ:KLDO

1 2 3 4 5 6 7 8 次へ >>

Invesco QQQ Trust Series 1

US Dollar vs Euro

JP Morgan Chase

Energy Select Sector SPDR

BNP Paribas (QX)

Verizon Communications

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約